Evidence map›Paper›PMID 39202556›Full record

ArticleMedicina (Kaunas, Lithuania)2024

Metformin in Chemoprevention of Lung Cancer: A Retrospective Population-Based Cohort Study in Lithuania.

Justinas Jonusas, Ausvydas Patasius, Mingaile Drevinskaite, Adomas Ladukas, Donata Linkeviciute-Ulinskiene, Lina Zabuliene, Giedre Smailyte

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Justinas JonusasLaboratory of Cancer Epidemiology, National Cancer Institute, LT-08406 Vilnius, Lithuania.ORCID 0000-0002-6457-4383
Ausvydas PatasiusLaboratory of Cancer Epidemiology, National Cancer Institute, LT-08406 Vilnius, Lithuania.ORCID 0000-0003-3874-2723
Mingaile DrevinskaiteLaboratory of Cancer Epidemiology, National Cancer Institute, LT-08406 Vilnius, Lithuania.
Adomas LadukasLaboratory of Cancer Epidemiology, National Cancer Institute, LT-08406 Vilnius, Lithuania.
Donata Linkeviciute-UlinskieneMedicine Clinic at Region Västmanland's Hospital Västerås, Sigtunagatan, 721 89 Västerås, Sweden.ORCID 0000-0003-1168-2003
Lina ZabulieneInstitute of Clinical Medicine, Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania.ORCID 0000-0002-7889-0862
Giedre SmailyteLaboratory of Cancer Epidemiology, National Cancer Institute, LT-08406 Vilnius, Lithuania.ORCID 0000-0001-8365-543X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 2Hypoglycemic AgentsLung NeoplasmsMetforminAdultAgedChemopreventionCohort StudiesFemaleHumansLithuaniaMaleMiddle AgedPioglitazoneProportional Hazards ModelsRetrospective StudiesHypoglycemic AgentsMetforminPioglitazonechemopreventiondose–response relationshiplung cancermetforminpioglitazonetype 2 diabetes mellitus

Identifiers

PMID39202556
PMCPMC11356288

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.